Outsmarting cancer is not a solo performance.
It's a team effort.
What we do at LUCC
Building
Community
Attracting talent; educating; nurturing the next generation of cancer researchers.
Enabling
Cutting-Edge Research
Sharing of knowledge and state-of-the-art equipment; attracting external funding.
Ensuring Fast Track
to Benefit Patients
Promoting innovation and collaboration between academia, hospitals and industry.
For every challenge in cancer research, someone has a solution, and LUCC helps me to find that person.
Gottfrid Sjödahl; Associate Professor at LUCC Urology
LUCC is an open network promoting education and supporting the next generation of cancer researchers.
Lisa Rydén, Professor of Surgery at LUCC
LUCC strategic networks
LUCC has 16 strategic translational networks based on cancer diagnosis, technology or processes. Each network is headed by one basic and one clinical researcher in most of the networks. The aim of the networks is to bridge the basic and clinical science and diverse disciplines. Networking activities include discussion about scientific challenges in the field, facilitation of new collaborations and sharing technical and scholar expertise. The key goal is to create opportunities that set the foundation for novel interdisciplinary research collaboration. Read more about all specific LUCC strategic networks: Breast, Child, CNS, Gastrointestinal, Gynecology, Head & neck, Hematology, Lung, Sarcoma, Skin, Urology, Cancer prevention, Clinical trials & diagnostics, Immunotherapy & tumour microenvironment, Nursing, rehabilitation and palliative care, Cancer epidemiology.
LUCC's core values
We Care
We take cancer seriously.
We want to improve quality of life.
We Collaborate
1 + 1 = 3
We provide an open and inclusive community.
We Go Beyond
We push the limits
to solve the cancer challenge.
News
LUCC brings cancer research to life at Kulturnatten 2026
More than 1,000 visitors explored the natural sciences at Vattenhallen during Kulturnatten 2026. At the LUCC stand, visitors discovered what a tumor looks like under a microscope a...
Lao Saal's innovation changes the cancer diagnosis options
Foundation Medicine, a subsidiary of Roche, acquired SAGA Diagnostics, a spin-off company of LUCC professor Lao Saal, in a deal worth up to $595 million. The key product, SAGA's Pa...
Three Tenure Track Positions available within Immunotherapy
LUCC is growing and currently 3 tenure track positions are available at our research environment. Three Assistant Professors in the field of Immunotherapy will be hired in the foll...
Forum Cancer in connection with World Cancer Day
Thank you to everyone who made their way through the snowstorm and made it to Forum Cancer in connection with World Cancer Day at Forum Medicum in Lund.
Centre for Interdisciplinary Research on Cancer and Equity in Women launches
A new research center CIRCE at Lund University have been granted long-term funding from Forte and VR at the end of 2025. It is led by LUCC researchers Lao Saal and Sophia Zackrisso...